Merck & Co., Inc. Defined Benefit Plan, Plan Assets, Payment for Settlement
Merck & Co., Inc. (MRK) reported Defined Benefit Plan, Plan Assets, Payment for Settlement of $21.00 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2024-05-03.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanSettlementsPlanAssets · last filed 2024-05-03
- Merck & Co., Inc. defined benefit plan, plan assets, payment for settlement for the quarter ending 2023-03-31 was $21.00M.
- Merck & Co., Inc. defined benefit plan, plan assets, payment for settlement for the quarter ending 2022-06-30 was $101.00M.
- Merck & Co., Inc. defined benefit plan, plan assets, payment for settlement for the quarter ending 2021-09-30 was $125.00M.
| Period end | Defined Benefit Plan, Plan Assets, Payment for Settlement 3 month | Defined Benefit Plan, Plan Assets, Payment for Settlement 6 month | Defined Benefit Plan, Plan Assets, Payment for Settlement 9 month |
|---|---|---|---|
| 2023-03-31 | $21.00M 10-Q · filed 2024-05-03 | ||
| 2022-06-30 | $101.00M 10-Q · filed 2022-08-05 | $101.00M 10-Q · filed 2022-08-05 | |
| 2021-09-30 | $125.00M 10-Q · filed 2021-11-05 | $125.00M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |